In our daily series of Q&As, we profile Bioeconomy Science Institute CEO Mark Piper.
UPDATE: NZX-listed company appears to deny A$70m capital raise accidently disclosed to ASX.
Milk processor to consult with staff and unions over next two weeks.
M-Co and Infratil keeping mum on bid for Aussie cancer care provider.
Strong wool now about half of volumes, but merino fetches five to six times the price.
Troubled projects at either end of Auckland backed by the same financier.
Nasdaq-listed powerhouse grew at 90% in NZ in 2020.
Bank’s No 2 to leave in January to pursue other interests.
Second fund likely after investment from first tops $110m.
Umbers has significant experience in the retail and grocery spaces.
